Champions Oncology Inc (CSBR): Target median analis

The market dynamics of Champions Oncology (CSBR) on the GURU.Markets platform show figures at 12.00, while the business relies on TumorGraft, a system for personalized oncology therapy selection. Stable management under Joel Beckerman is developing data services, strengthening confidence through effective unit economics. However, Champions Oncology (CSBR) must compete for pharma contracts against AI platforms capable of replacing physical tests.

Champions Oncology Inc - Bagan rega target CSBR (periode 04.07.2022 - 22.10.2026)

Rincian analitis perusahaan Champions Oncology (CSBR)

Indikator analitis utama championsoncology.com (CSBR):

Kutipan saham championsoncology.com|CSBR - Bagan rega target|Kapitalisasi pasar Champions Oncology Corp

Analisis fundamental perusahaan:Champions Oncology Inc (CSBR)

Produk asli Champions Oncology

The scaling of IT platforms and the Lumin base for biopharmaceuticals directly impacts the median analyst price target, which synthesizes independent assessments of the fundamental value of Champions Oncology (CSBR). This indicator measures market expectations for the company's expansion, allowing investors to evaluate how strategic successes are discounted into the asset price, although general market risks continue to influence final portfolio returns.

Perusahaan pesaing

Target konsensus beigene.com ONC|Bagan rega target Halozyme HALO|Target median analis Revolution Medicines Inc (RVMD)|Ascentage - Prakiraan konsensus analis|CGON: Bagan rega target|UroGen Pharma Ltd. (URGN) - Bagan rega target|bicara.com - Konsensus nilai wajar|PSNL (Personalis) - Prakiraan konsensus analis|Target konsensus Erasca Inc (ERAS)|Prakiraan konsensus analis DCTH|Prakiraan konsensus analis Y-mAbs Corp (YMAB)|Bagan rega target Aura Biosciences, Inc. AURA|CADL: Prakiraan gabungan firma investasi|Accuray - Prakiraan konsensus analis|SELLAS Life Sciences (SLS) - Target konsensus|ACTU: Prakiraan konsensus analis|Rata-rata rega prakiraan Citius Oncology Inc (CTOR)|Bagan rega target TuHURA Biosciences Inc.|TARA: Konsensus nilai wajar|Target konsensus FATE (Fate Therapeutics)|WHWK (aadibio.com) - Konsensus nilai wajar|Prakiraan konsensus analis TCRX (TScan Therapeutics, Inc.)|XBIT - Target konsensus|CVM: Target konsensus|OSTX - Prakiraan konsensus analis|Radiopharm Theranostics Limited (RADX) - Bagan rega target|Artiva Biotherapeutics - Konsensus nilai wajar|ANL (Adlai Nortye Ltd) - Prakiraan konsensus analis|Rata-rata rega prakiraan Veru Corporation VERU|Prakiraan konsensus analis TPST|Target konsensus xiliotx.com XLO|Prakiraan konsensus analis RENB (Renovaro)|Konsensus nilai wajar MURA|Kairos Pharma Inc - Prakiraan konsensus analis|OKUR - Prakiraan konsensus analis|w2.cytomed.sg (GDTC) - Bagan rega target|Target konsensus Curis|Bagan rega target Apollomics Inc.|Tharimmune Inc - Bagan tingkat prakiraan|Prakiraan konsensus analis ADVB|Target median analis Genprex Inc|Bagan rega target Calidi Biotherapeutics, Inc. CLDI|Sunshine Biopharma Inc. (SBFM) - Rata-rata rega prakiraan|XBIO - Bagan rega target|SLRX (Salarius Pharmaceuticals Inc) - Prakiraan gabungan firma investasi|Purple Biotech Corp (PPBT) - Bagan rega target|AONC - Target median analis|Target konsensus BGNE|CKPT: Konsensus nilai wajar|Bagan rega target Elevation Oncology, Inc. (ELEV)|ICAD - Rata-rata rega prakiraan|Bagan rega target Ikena Oncology IKNA|NTBL: Prakiraan gabungan firma investasi|Viracta - Prakiraan konsensus analis|morphosys.com (MOR) - Target konsensus|NAYA Biosciences Inc. (NAYA) - Bagan rega target|Rata-rata rega prakiraan Ascentage Pharma Group International (AAPGV)